Concepedia

Smitha Antony

SA

Statistics

Publications

59

Citations

3.7K

H-Index

40

Active since

2003

Affiliations

Center for Cancer Research(Current)

National Cancer Institute

National Institutes of Health

Purdue University West Lafayette

Frederick National Laboratory for Cancer Research

Smitha Antony is an author at Center for Cancer Research specializing in pharmacology, topoisomerase i inhibitors, and medicinal chemistry.

ORCID

Publications per year

2003–2023

59

Publications

59

Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites

Christophe Marchand, Krzysztof Krajewski, Hsiu-Fang Lee et al. · Nucleic Acids Research · 2006 · 172 citations · Full text

, , +17

A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex

Christophe Marchand, Smitha Antony, Kurt W. Kohn et al. · Molecular Cancer Therapeutics · 2006 · 162 citations · Full text

, , +14

Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA‐PK

Benu Brata Das, Smitha Antony, Shalu Gupta et al. · The EMBO Journal · 2009 · 149 citations · Full text

, , +11

Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Featuring Polyamine Side Chains on the Lactam Nitrogen

Muthukaman Nagarajan, Xiangshu Xiao, Smitha Antony et al. · Journal of Medicinal Chemistry · 2003 · 129 citations

, , +13

Synthesis and Anticancer Activity of Simplified Indenoisoquinoline Topoisomerase I Inhibitors Lacking Substituents on the Aromatic Rings

Muthukaman Nagarajan, Andrew Morrell, Brian C. Fort et al. · Journal of Medicinal Chemistry · 2004 · 129 citations

, , +14

1–5 of 59